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Abstract
Background. Family doctors can only play a role in the prevention of excessive substance use in 
young people if those affected are seen in the practice.
Objective. To describe the prevalence of excessive substance use among young people consulting 
family doctors in a European context.
Methods. As part of a trial of an intervention addressing substance use we collected data from 
young people consulting 32 family doctors in the French-speaking part of Switzerland. Before the 
consultation, consecutive patients aged 15–24 years completed a self-administered questionnaire 
on their general health and substance use. Outcomes were excessive alcohol (defined as ≥1 
episode of binge drinking), excessive cannabis (use ≥1/week), regular tobacco (≥1 cigarettes a day) 
and/or any other substance use in the past 30 days. Prevalence data were computed with 95% 
confidence intervals (CIs) adjusted for clustering within practices, stratified by age and gender.
Results. Between February 2009 and November 2010, 636 patients were eligible. Participation rate 
was 93.4% (n = 594, 53% female). The prevalence of excessive use in the past 30 days was alcohol 
44.9% (95% CI: 37.8–52.1), cannabis 11.1% (95% CI: 8.0–14.1), tobacco 23.4% (95% CI: 19.0–28.1) and any 
other drug 2.6 (95% CI: 1.4–4.2). Excessive use was higher in males than in females. Except for tobacco 
prevalence of excessive use was only slightly higher in young adults compared to adolescents.
Conclusion. Excessive substance use is frequent among young people consulting family doctors 
in a European context. Future research should provide guidance about how to best seize this 
window of opportunity for prevention and early intervention.
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Introduction 
Adolescence and young adulthood are periods of exploration during 
which young people often initiate substance use. For many young 
people use is only brief but for others this exploration leads to sub-
stance misuse with consequences that affect adolescents’ development 
and their entire adult life (1). Because interventions have been shown 
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to be effective in the clinical setting, the US preventive task force rec-
ommends screening and brief intervention for alcohol misuse in adults 
as from the age of 18 years seen in primary care (2). Some say these 
recommendations should extend to adolescents but in the absence of 
evidence in favour of effective interventions in this age group no clear 
recommendation has been issued (1–3). Similarly, due to a lack of 
studies in this context, the value of screening for illicit substance use 
in primary care, both in adolescents and in adults, remains debated 
(2). In addition to having doubts in relation to the effectiveness of 
screening and interventions to address excessive substance use in this 
patient group, and facing other barriers such as time constraints and 
lack of expertize in this field, family doctors may also believe that 
harmful substance use is less common among their younger patients 
(4,5). Screening for alcohol and illicit drug use may therefore not 
be high on their priority list (6). Yet population-based studies sug-
gest that excessive alcohol (i.e. in this age group mainly binge drink-
ing) and/or cannabis use is not uncommon among adolescents and 
young adults in Europe and the USA. Thirty to 50% of them report 
binge drinking and ~10% use cannabis on a regular basis (7–11). 
Tobacco use remains frequent in Europe with prevalence rates rang-
ing between 20% and 40% among young adults (10–13). Analysing 
data from a population-based study in Switzerland, we have shown 
that young people engaging in health compromising behaviours were 
as likely as others to visit a family doctor at least once a year (14). 
Thus the proportion of young people engaging in excessive substance 
use is likely to be high among young people in family practice. Yet we 
found no studies reporting the prevalence of excessive substance use 
among young people consulting family doctors in Europe. The extent 
to which family doctors have opportunities to address this problem is 
therefore unknown. To date many studies in relation to substance use 
in young people have been conducted in the USA, a country in which 
alcohol and substance use are totally prohibited in adolescence (15). 
In addition, these studies often focus on the identification of problem 
or dependant users who may need specialized care, rather than on 
excessive users who could benefit from early primary care interven-
tions to modify their behaviour (1,16,17). Family doctors working 
in countries in which underage drinking is not illegal and occasional 
cannabis use tolerated may struggle to differentiate occasional users 
from excessive users among their young patients (18). A clearer defi-
nition of excessive use and an estimate of the expected prevalence 
of such use among young people seen in family practice could guide 
primary care providers in their screening task.
Comparatively fewer doubts surround screening for tobacco use 
in young people in primary care: daily use is a common threshold to 
define unhealthy tobacco use, and both interventions to prevent ini-
tiation and those addressing regular use appear to be effective in this 
context (2). Tobacco use often begins in adolescence and population-
based studies show that regular tobacco use remains frequent in the 
European context.
The aim of this study was to measure the prevalence of exces-
sive alcohol and illicit drug use and of tobacco use in young people 
consulting family doctors in Switzerland in order to provide guid-
ance about opportunities for prevention and early intervention in a 
European context.
Methods
This cross-sectional study used baseline data collected as part of 
the Primary care Intervention Addressing Substance Misuse in 
Adolescents (PRISM-Ado) trial, a cluster randomized trial of the 
effectiveness of training primary care physicians to use a brief inter-
vention to address excessive substance use in young people (19).
The study protocol was approved by the Ethics Committee for 
Studies in Outpatient Care (protocol 08–28).
Participants and procedure
Young people between the ages of 15 and 24 years were recruited 
in the practices of 32 family doctors (general internists and general 
paediatricians) in the French-speaking part of Switzerland. Patients 
with any problem affecting their ability to consent (such as trauma 
or acute illness requiring immediate attention, inability to read and 
understand French, severe mental illness) were excluded, as were 
those currently or recently undergoing treatment for substance 
dependence. The physicians were volunteers participating in the 
PRISM-Ado trial. Most had experience in addressing excessive alco-
hol use in adults, but were not used to discussing substance use issues 
with young people in their practice (19). Consecutive young people 
consulting for any motive were invited to complete a confidential 
questionnaire about their health and substance use in the wait-
ing room before the consultation. Completed questionnaires were 
placed in a sealed envelope and forwarded directly to the research 
team. They were not made available to the primary care physician 
in the consultation.
The choice of the age range 15–24 years (‘youth’ according to the 
United Nations definition) was based on two considerations: (i) young 
people in this age group share a similar burden of disease throughout 
this developmental phase from adolescence into adulthood (20) and 
(ii) from the age of 15 years they can participate in low-risk studies 
such as this one without asking for parental consent (21).
Measures
Questions about substance use were taken from the Dep-Ado clini-
cal questionnaire, a validated substance use screening tool in French 
(22). Patients were asked about the frequency of various substance 
uses over the past 30  days, age of initiation, frequency of binge 
drinking and psychosocial consequences.
We defined excessive alcohol use as at least one episode of binge 
drinking in the past 30 days, based on a 2- to 6-fold increased risk 
of adult dependence and adverse psychosocial outcomes in young 
people with such levels of use in cohort studies (23,24). As in other 
previous European studies, a binge drinking episode was defined as 
the consumption of five drinks (four for females) or more on one 
occasion (10,24,25). Similarly, as this level of use in adolescence has 
been associated with a 2- to 10-fold increase in adverse outcomes in 
adulthood, we set the threshold for excessive cannabis use at once a 
week or more frequently in the past 30 days (26). The questions were 
‘In the past 30 days, how many times did you have 5 (4 drinks for 
females) drinks of alcohol or more on the same occasion?’ and ‘In 
the past 30 days, did you use cannabis? If so, how often?’ Response 
options were approximately once; on weekends or once or twice dur-
ing the week; three times or more a week but not every day; or every 
day. The young people were instructed to consider as a drink ‘what is 
usually served in a restaurant if you order this type of alcohol’.
Socio-demographic variables were also measured: patient’s age, 
gender, country of birth, school or professional activity and rural or 
urban doctor’s practice.
Statistical analysis
Binary or categorical variables were described using proportions and 
95% confidence intervals adjusted for clustering within practices, 
stratified by gender and by age group (minors of less than 18 years 
old versus young adults of 18 years and over, since recommendations 
for screening and intervention are different in these two age groups). 
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Logistic regression adjusted for clustering was used to explore the 
association between socio-demographic characteristics and excessive 
alcohol, cannabis or tobacco use. We used Stata software to analyse 
the data.
Results
Between February 2009 and November 2010, 636 patients were eli-
gible for the study. 40 (6.3%) declined and two did not complete 
the baseline survey. Thus participation rate was 93.4% (n = 594). 
Most patients reported consulting for general reasons (check-up or 
immunization), common respiratory or skin disorders, or depressive 
symptoms. Only four patients reported substance use as their main 
reason for encounter (19).
Table  1 summarizes participants’ main socio-demographic 
characteristics, stratified by gender. There were missing substance 
(mainly binge drinking) use data for 24 patients, whose characteris-
tics were slightly different from the others: they were more likely to 
be migrants to Switzerland and less likely to be students.
Most patients (75%) had drunk alcohol, 45% had smoked at 
least one cigarette and nearly 20% had used cannabis at least once 
in the past 30 days. Excessive alcohol use was common, particularly 
in males. Approximately 10% of patients reported smoking can-
nabis at least once a week and ~25% smoked at least one ciga-
rette a day (Table 2). Binge drinking was significantly less frequent 
among patients consulting in urban compared to non-urban prac-
tices (37.6% versus 56.9%, odds ratio [OR]  =  0.5, P  =  0.006). 
Multivariate logistic regression adjusting for socio-demographic var-
iables and clustering within practices also showed that binge drink-
ing behaviour was significantly less frequent in females (OR = 0.43, 
P < 0.001) and in students (OR = 0.67, P = 0.03). Excessive can-
nabis use was more common in the urban context (13.0% versus 
8.0%, OR = 2.2, P = 0.005), but was, as binge drinking, less fre-
quent in females (OR = 0.29, P < 0.001) and in students (OR = 0.52, 
P  =  0.003). Daily smoking was less frequent in adolescents than 
young adults (OR  =  0.6, P  =  0.01) and in students (OR  =  0.36, 
P < 0.001). These associations remained similar when additionally 
adjusting for maternal education, as a (imperfect) proxy measure of 
socio-economic status (27). Less than 3% of participants reported 
other drug use (cocaine, ecstasy etc.) in the past month.
Discussion
Summary of main findings
This study reports on the prevalence of excessive substance use among 
young people aged 15–24  years old consulting family doctors in a 
European context. Binge drinking behaviour was frequent with nearly 
half of the patients reporting at least one episode of binge drinking 
in the past 30 days. One in 4 patients smoked cigarettes daily and 
Table 1. Characteristics of 594 patients aged between 15 and 24 years recruited before their consultation with one of 32 family doctors 
involved in the study (numbers are percentages unless indicated otherwise)
Characteristic Patients without missing substance 
use data (n = 570)
Patients with missing substance use 
data (n = 24)
Total sample
Male (n = 265) Female (n = 305) Male ( n = 13) Female (n = 11) (n = 594)
Mean age, years (SD) 18.4 (2.5) 18.6 (2.7) 17.7 (1.7) 18.2 (2.2) 18.5 (2.6)
Born in Switzerland 87.5 82.6 53.8 81.8 84.2
Student 47.9 63.3 23.1 45.5 55.2
Self-assessed health good, very good or excellent 98.9 95.2 100 90.9 96.9
Doctor in urban area 57.0 66.6 38.5 45.5 61.3
SD, standard deviation.
Table 2. Prevalence of substance use in patients aged 15–24 years consulting in primary care practice in the French-speaking part of Swit-
zerland, by gender and age-group (adolesents versus young adults)a
Substance use in past 
30 days
Total sampleb Maleb Femaleb 15–17 years oldb 18–24 years oldb
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Alcohol
 No alcohol use 25.0 (19.9–30.0) 18.5 (12.4–24.5) 30.6 (24.5–36.8) 36.1 (29.0–43.1) 16.9 (12.3–21.5)
 Binge drinking at least 
once
44.9 (37.8–52.1) 57.4 (48.2–66.4) 34.1 (28.0–40.2) 42.1 (34.6–49.5) 47.0 (37.7–56.3)
Cannabis
 No cannabis use 81.1 (77.3–84.5) 73.5 (67.6–79.5) 87.6 (84.1–91.2) 84.5 (79.2–89.9) 78.6 (73.7–83.5)
 Cannabis use at least once 
a week
11.1 (8.0–14.1) 17.2 (12.3–22.2) 5.7 (2.8–8.7) 8.5 (4.7–12.3) 12.9 (8.9–16.9)
Other illegal substancea
 Any use 2.6 (1.4–4.2) 3.8 (1.8–6.8) 1.6 (0.5–3.8) 2.1 (0.7–4.8) 3.0 (1.5–5.5)
Tobacco
 No tobacco use 56.3 (52.1–60.5) 51.5 (45.3–57.7) 60.4 (55.1–65.8) 62.3 (56.1–68.6) 51.8 (47.6–56.0)
 Daily tobacco use 23.4 (19.0–28.1) 26.7 (20.1–33.2) 20.9 (15.4–26.4) 15.8 (10.8–20.8) 29.3 (24.2–34.5)
CI, confidence interval.
aEcstasy, cocaine, heroin, lysergic acid diethylamide (LSD), amphetamins.
bN varied due to missing values. Total sample: 570–587; males: 265–272; females: 305–316; 15–17 years old: 240–247; 18–24 years old: 330–341.
Substance use in young people in FP 503
approximately 1 in 10 were regular cannabis users. Substance use was 
more common in males but prevalence rates were also high in females, 
particularly for binge drinking (34%). Binge drinking was more com-
mon in non-urban areas and cannabis use more prevalent in urban 
areas. Students (in secondary school or university) were less likely to 
report excessive substance use or regular smoking. Differences between 
adolescents and young adults were modest, except for smoking.
Interpretation of findings and comparison with 
previous literature
These findings are in line with results from population-based studies, 
thus confirming, if need be, that in a country with universal health 
coverage young people consulting in family practice are an unse-
lected population (8,10–12,28). This resonates with our previous 
finding that young people with health-compromising behaviours 
were as likely as others to visit family doctors (28,29).
Our results differ from those reported by Gryczynski et al. (16) in 
a study conducted among adolescents in health centres in Baltimore, 
MD, USA, in which the prevalence of problem and/or dependent 
users was 9.4% for alcohol, 15.3% for cannabis and 6.1% for 
tobacco. This study included younger adolescents (from the age of 
12), and used definitions of problem use based on the presence of at 
least one Diagnostic and Statistical Manual of Mental Disorders, 5th 
Edition criterion. Thus, it focused on adolescents who may already 
need addiction treatment, rather than on all those who could ben-
efit from prevention or early intervention in a primary care context. 
Similarly, another study conducted in primary care practices in the 
USA, using the CRAFFT screening tool, reported a prevalence of 
15% for at-risk substance use among adolescents between the ages 
of 12 and 18 years old (30). We found no previous study specifi-
cally describing the prevalence of substance use among young adults 
(18–24 years old) consulting in primary care.
Strengths and limitations
Recruitment of patients occurred directly in the practices and could 
not be supervised by the research team. However, in order to make 
recruitment easier and minimize selection bias (that could occur if 
practice staff were asked to invite selected types of patients to par-
ticipate), the study involved consecutive young people consulting 
their family doctor for any reason. Participation rate was high, and 
the young people could consent to participation without asking their 
parents, thus favouring participation and further limiting a poten-
tial selection bias (31). This cross-sectional study did not involve 
a random sample of family doctors. Participating family doctors 
were volunteers, with a special interest in the theme of young peo-
ple and substance use. Thus the patients seen in their practices may 
not entirely be representative of the patients usually seen by family 
doctors in the French-speaking part of Switzerland. However, these 
doctors were not experts in addiction medicine, as illustrated by the 
fact that only four patients consulted specifically for a substance-use-
related problem. Data were collected through self-report, and thus 
some level of under-reporting of substance use cannot be excluded. 
However, self-report of substance use has previously been shown to 
be a reliable measure in young people (32). We used a paper-based 
anonymous questionnaire to collect data about substance use, a pre-
ferred and reliable option for studies involving young people (32,33). 
The data they provided were not made available to the doctors. As 
young people previously highlighted, this is likely to have favoured 
honest responses from young people about substance use (33,34). 
However, as a consequence, our results provide no information 
about the proportion of young people who would be prepared to 
discuss their substance use with their family doctor. We chose thresh-
olds for excessive substance use based on data from cohort studies 
reporting increased risk of adverse adult outcomes for young people 
with that level of use (23,24,26,35). This definition was also inspired 
by definitions of excessive alcohol use in adults (18). However, other 
studies in primary care have used other definitions of excessive use, 
thus limiting the comparisons that can be made.
Implications for clinical practice and future research
Our findings suggest that excessive substance use is frequent among 
young people consulting family doctors in a European context. Thus 
family doctors have opportunities for prevention and early interven-
tion addressing substance use in this age group. Most young people 
did not present with a substance-related motive for encounter. This 
highlights the need to favour opportunistic screening in this context. 
Smoking was significantly more common in young adults compared 
to adolescents: the window of opportunity for prevention in the 
younger age group should not be neglected. Although brief interven-
tions addressing excessive substance use in adults have been shown 
to be effective, evidence is still lacking in relation to effective preven-
tive and early intervention strategies for adolescents and young adults 
consulting in primary care (2). In the PRISM-Ado trial we showed 
that overall there was a 28% reduction in the proportion of young 
patients reporting excessive alcohol and/or cannabis use 12 months 
after a consultation with a family doctor, regardless of whether they 
had been exposed to a specific intervention (19). This suggests that 
there might be a positive impact of screening alone, be it by just 
completing a survey in the waiting room or in the consultation (36). 
Further research should focus on the development of effective screen-
ing strategies in primary care, as well as the search for evidence in 
favour of effective preventive and early intervention strategies (19,37). 
Since the immediate consequences of substance use are particularly 
conspicuous in young adults (for example mortality from road traffic 
injuries is highest in young adults (38)), a particular emphasis should 
be placed on the development of interventions that are responsive to 
young adults’ needs (39,40). The role that family and peers may play 
to support primary care interventions also deserves attention.
Conclusion
Half of the adolescents and young adults visiting their family doctor 
in a European context reported excessive substance use, even though 
very few consulted for this reason. Although evidence for effective 
interventions is lacking, systematic screening for substance use in 
primary care seems justified in this age group.
In view of the important burden of disease related to these health-
compromising behaviours both in young people and in adults, prior-
ity should be given to the further development and trial of effective 
approaches to address excessive substance use in adolescents and 
young adults consulting in family practice.
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